GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » YoY EBITDA Growth

Curative Biosciences (Curative Biosciences) YoY EBITDA Growth : 0.00% (As of Mar. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Curative Biosciences's YoY EBITDA Growth for the quarter that ended in Mar. 2018 was 0.00%.

Curative Biosciences's EBITDA per Share for the three months ended in Mar. 2018 was $-0.00.


Curative Biosciences YoY EBITDA Growth Historical Data

The historical data trend for Curative Biosciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences YoY EBITDA Growth Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.01 99.20 -93.91 46.64 97.48

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 75.00 50.00 - -

Curative Biosciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Curative Biosciences's YoY EBITDA Growth for the fiscal year that ended in Jun. 2017 is calculated as:

YoY EBITDA Growth (A: Jun. 2017 )
=(EBITDA per Share (A: Jun. 2017 )-EBITDA per Share (A: Jun. 2016 ))/ | EBITDA per Share (A: Jun. 2016 ) |
=(-0.003--0.119)/ | -0.119 |
=97.48 %

Curative Biosciences's YoY EBITDA Growth for the quarter that ended in Mar. 2018 is calculated as:

YoY EBITDA Growth (Q: Mar. 2018 )
=(EBITDA per Share (Q: Mar. 2018 )-EBITDA per Share (Q: Mar. 2017 )) / | EBITDA per Share (Q: Mar. 2017 )) |
=(-0.002--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biosciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines